Health Catalyst, Inc. 8-K
Research Summary
AI-generated summary
Health Catalyst Reports Q4 and Full-Year 2025 Financial Results
What Happened
On March 12, 2026, Health Catalyst, Inc. (HCAT) announced via press release its financial results for the quarter and fiscal year ended December 31, 2025. The company furnished the press release as Exhibit 99.1 to an SEC Form 8‑K (Item 2.02: Results of Operations and Financial Condition). The filing notes the information is being furnished — not “filed” — under the Securities Exchange Act. The Form 8‑K was signed by Chief Financial Officer Jason Alger.
Key Details
- Filing date: March 12, 2026 (Form 8‑K).
- Reporting periods: quarter and year ended December 31, 2025.
- Exhibit included: 99.1 — Health Catalyst press release (furnished, not filed).
- Form signed by: Jason Alger, Chief Financial Officer.
Why It Matters
This 8‑K signals that Health Catalyst has released its quarterly and full‑year financial results — the primary source for updated information on earnings, revenue, margins, and management commentary for those periods. Because the release is furnished rather than filed, it is included in the SEC record for investors to review but is subject to different legal liability standards. Retail investors should read the attached press release and any accompanying financial statements or earnings materials (and monitor subsequent filings like the annual 10‑K) to see actual revenue, net income, guidance, and management discussion that may affect the stock. Keywords: earnings, revenue, quarterly results, CFO.
Loading document...